10X Genomics, Inc. (TXG)
23.01
+1.19
(+5.45%)
USD |
NASDAQ |
Apr 08, 13:13
10X Genomics Cash from Investing (TTM) : -13.44M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Omnicell, Inc. | -60.36M |
| Phreesia, Inc. | -161.88M |
| American Shared Hospital Services | -7.626M |
| WW International, Inc. | -19.50M |
| Pacific Health Care Organization, Inc. | -0.9901M |